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NO-sensitive guanylyl cyclase (NO-GC) is accepted to
be the major receptor for the signaling molecule NO.
Deletion of NO-GC in mice leads to disturbed NO/
cGMP signaling. As a result, these mice show abolished
NO-dependent relaxation of smooth muscle-containing
tissues in the cardiovascular and gastrointestinal sys-
tems. Mice with general deletion (GCKO) suffer from
increased blood pressure, reduced bleeding time, erectile
dysfunction and die prematurely due to gastrointestinal
dysmotility. Mice lacking NO-GC specifically in smooth
muscle cells (SMC) show an elevated blood pressure
similar to that seen in GCKO animals.
Crosstalk between cGMP and cAMP signaling has been
reported to occur in many different cells. Phosphodies-
terase 3 (PDE3) is thought to be one of the prominent
mediators of this crosstalk. Through its inhibitory action
on PDE3, cGMP may regulate cAMP levels and cAMP-
mediated signaling. Here, we reasoned that, in animals
deficient in NO-GC, lack of NO-induced cGMP synthesis
might affect cGMP/cAMP crosstalk on the level of PDE3.
Smooth muscle relaxation induced by forskolin to stimu-
late adenylyl cyclase was similar in WT, GCKO and
SMC-GCKO aortae. RIA-based detection of basal cAMP
levels in aortic tissue from these mice did not reveal dif-
ferences. Similarly, FRET measurements showed that
PGE1-induced cAMP synthesis in isolated smooth mus-
cle cells was unaffected by NO-GC deletion. However,
aortae from GCKO and SMC-GCKO animals were more
sensitive to milrinone, a specific inhibitor of PDE3, as the
concentration curve for relaxation was shifted to the left.
Analysis of PDE3 expression in aorta showed an approxi-
mately 50% reduction in PDE3 protein and specific
enzyme activity. Similar reduction was detected in plate-
lets but not in heart tissue of GCKO animals.
Induction of SMC-specific NO-GC deletion by tamoxi-
fen led to a parallel decline of NO-GC and PDE3 expres-
sion. Both proteins were strongly reduced already 5 days
after the last tamoxifen injection. In contrast, systolic
blood pressure in these animals started to rise only after
10 days and was maximal after 50 days. These data indi-
cate that cGMP, not the increase in blood pressure, is
responsible for the expression regulation of PDE3. We
conclude that cGMP modulates PDE3 expression in
SMC in order to keep up functional cAMP signaling.
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